Patents by Inventor Uriel Halavee

Uriel Halavee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230381227
    Abstract: The present invention relates to products and methods for treatment of hair loss. Specifically, the present application relates to compositions and methods for prevention and treatment of hair loss, comprising administration of a composition comprising intact mitochondria, ruptured mitochondria and/or mitochondrial constituents.
    Type: Application
    Filed: August 8, 2023
    Publication date: November 30, 2023
    Inventors: Natalie YIVGI-OHANA, Uriel Halavee, Shmuel Bukshpan
  • Patent number: 11441124
    Abstract: The present invention provides human bone-marrow cells enriched with functional mitochondria, methods for their production, and therapeutic methods utilizing such cells.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: September 13, 2022
    Assignee: Minovia Therapeutics Ltd.
    Inventors: Natalie Yivgi-Ohana, Uriel Halavee
  • Patent number: 11351195
    Abstract: Mitochondrial compositions and therapeutic methods of using same. Compositions of partially purified functional mitochondria and methods of using the compositions to treat conditions which benefit from increased mitochondrial function by administering the compositions to a subject in need thereof.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: June 7, 2022
    Assignee: Minovia Therapeutics Ltd.
    Inventors: Natalie Yivgi-Ohana, Uriel Halavee
  • Publication number: 20210322485
    Abstract: The present invention provides stem cells enriched with healthy functional mitochondria, and therapeutic methods utilizing such cells for the alleviation of debilitating conditions, including aging, and age-related diseases as well as the debilitating effects of anti-cancer therapies in subjects in need thereof.
    Type: Application
    Filed: July 22, 2019
    Publication date: October 21, 2021
    Inventors: Natalie Yivgi Ohana, Uriel Halavee, Shmuel Bukshpan, Noa Sher
  • Publication number: 20210290691
    Abstract: The present invention provides stem cells enriched with healthy functional mitochondria, pharmaceutical compositions comprising these cells and methods of use thereof for treating muscle diseases, disorders and symptoms thereof where the disease may or may not be associated with acquired mitochondrial dysfunction.
    Type: Application
    Filed: July 22, 2019
    Publication date: September 23, 2021
    Inventors: Natalie Yivgi Ohana, Uriel Halavee, Shmuel Bukshpan, Noa Sher, Moriya Blumkin
  • Publication number: 20210275599
    Abstract: The present invention provides stem cells enriched with healthy functional mitochondria, pharmaceutical compositions comprising these cells and methods of use thereof for treating brain diseases, disorders and symptoms thereof where the disease may or may not be associated with acquired mitochondrial dysfunction.
    Type: Application
    Filed: July 22, 2019
    Publication date: September 9, 2021
    Inventors: Natalie Yivgi Ohana, Uriel Halavee, Shmuel Bukshpan, Noa Sher, Moriya Blumkin
  • Publication number: 20210275597
    Abstract: The present invention provides stem cells enriched with healthy functional mitochondria, pharmaceutical compositions comprising these cells and methods of use thereof for treating ocular diseases, disorders and symptoms thereof where the disease may or may not be associated with acquired mitochondrial dysfunction.
    Type: Application
    Filed: July 22, 2019
    Publication date: September 9, 2021
    Inventors: Natalie Yivgi Ohana, Uriel Halavee, Shmuel Bukshpan, Noa Sher, Moriya Blumkin
  • Publication number: 20210275587
    Abstract: The present invention provides stem cells enriched with healthy functional mitochondria, pharmaceutical compositions comprising these cells and methods of use thereof for treating renal diseases, disorders and symptoms thereof where the disease may or may not be associated with acquired mitochondrial dysfunction.
    Type: Application
    Filed: July 22, 2019
    Publication date: September 9, 2021
    Inventors: Natalie Yivgi Ohana, Uriel Halavee, Shmuel Bukshpan, Moriya Blumkin, Noa Sher
  • Publication number: 20210260137
    Abstract: The present invention provides human stem cells enriched with functional mitochondria, wherein the healthy functional exogenous mitochondria constitute at least 3% and less than 33% of the total mitochondria in the mitochondrially-enriched human stem cells. Further disclosed are methods for the production of such cells, and uses thereof for the treatment of primary mitochondrial diseases.
    Type: Application
    Filed: July 22, 2019
    Publication date: August 26, 2021
    Inventors: Natalie Yivgi Ohana, Uriel Halavee, Shmuel Bukshpan, Noa Sher, Moriya Blumkin
  • Publication number: 20210252075
    Abstract: The present invention provides stem cells enriched with healthy functional mitochondria, pharmaceutical compositions comprising these cells and methods of use thereof for treating liver diseases, disorders and symptoms thereof where the disease may or may not be associated with acquired mitochondrial dysfunction.
    Type: Application
    Filed: July 22, 2019
    Publication date: August 19, 2021
    Inventors: Natalie Yivgi Ohana, Uriel Halavee, Shmuel Bukshpan, Noa Sher, Moriya Blumkin
  • Publication number: 20210228642
    Abstract: The present invention provides stem cells enriched with healthy functional mitochondria, pharmaceutical compositions comprising these cells and methods of use thereof for treating pancreatic diseases, disorders and symptoms thereof where the disease may or may not be associated with acquired mitochondrial dysfunction.
    Type: Application
    Filed: July 22, 2019
    Publication date: July 29, 2021
    Inventors: Natalie Yivgi Ohana, Uriel Halavee, Shmuel Bukshpan, Noa Sher, Moriya Blumkin
  • Publication number: 20210205368
    Abstract: The present invention provides stem cells enriched with healthy functional mitochondria, pharmaceutical compositions comprising these cells and methods of use thereof for treating renal diseases, disorders and symptoms thereof where the disease may or may not be associated with acquired mitochondrial dysfunction.
    Type: Application
    Filed: March 19, 2021
    Publication date: July 8, 2021
    Inventors: Natalie Yivgi Ohana, Uriel Halavee, Shmuel Bukshpan, Moriya Blumkin, Noa Sher
  • Publication number: 20210023143
    Abstract: The present invention relates to methods of using compositions comprising intact mitochondria and/or ruptured mitochondria for elevating lipid metabolism in cells. The present invention further provides methods for treating diseases which benefit from elevation of lipid and cholesterol metabolism and methods for inducing weight loss or reducing weight gain comprising administering compositions comprising intact mitochondria and/or ruptured mitochondria to a subject in need thereof.
    Type: Application
    Filed: March 26, 2019
    Publication date: January 28, 2021
    Inventors: Natalie Yivgi Ohana, Uriel Halavee, Shmuel Bukshpan
  • Publication number: 20200246379
    Abstract: The present invention relates to mitochondrial compositions and therapeutic methods of using same.
    Type: Application
    Filed: March 30, 2020
    Publication date: August 6, 2020
    Inventors: Natalie YIVGI-OHANA, Uriel HALAVEE
  • Patent number: 10735933
    Abstract: A method for communicating with a given device that is located at a given direction, the method may include transmitting a triggering signal, by a communication device and over a directional communication link; receiving, by the communication device, one or more responses to the triggering signal, wherein the one or more responses originate from one or more devices; participating in determining of whether the one or more devices comprises the given device or receiving indication about whether the one or more devices comprises the given device; and when the one or more devices comprises the given device then attempting, by the communication device, to establish communication with the given device.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: August 4, 2020
    Assignee: SONULAR LTD.
    Inventors: Uriel Halavee, Jonathan Halavee, Arie Gavriely
  • Publication number: 20200239850
    Abstract: The present invention provides human bone-marrow cells enriched with functional mitochondria, methods for their production, and therapeutic methods utilizing such cells.
    Type: Application
    Filed: March 24, 2020
    Publication date: July 30, 2020
    Inventors: Natalie YIVGI-OHANA, Uriel HALAVEE
  • Patent number: 10702556
    Abstract: The present invention relates to compositions and methods of inducing angiogenesis and methods of treating a pathology that would benefit from angiogenesis by use of a composition comprising partially purified intact mitochondria and/or ruptured mitochondria derived therefrom.
    Type: Grant
    Filed: May 16, 2013
    Date of Patent: July 7, 2020
    Assignee: Minovia Therpautices Ltd.
    Inventors: Natalie Yivgi-Ohana, Uriel Halavee, Shmuel Bukshpan
  • Publication number: 20200023005
    Abstract: The present invention relates to products and methods for treatment of hair loss. Specifically, the present application relates to compositions and methods for prevention and treatment of hair loss, comprising administration of a composition comprising intact mitochondria, ruptured mitochondria and/or mitochondrial constituents.
    Type: Application
    Filed: March 22, 2018
    Publication date: January 23, 2020
    Inventors: Natalie YIVGI-OHANA, Uriel HALAVEE, Shmuel BUKSHPAN
  • Publication number: 20190364411
    Abstract: A method for communicating with a given device that is located at a given direction, the method may include transmitting a triggering signal, by a communication device and over a directional communication link; receiving, by the communication device, one or more responses to the triggering signal, wherein the one or more responses originate from one or more devices; participating in determining of whether the one or more devices comprises the given device or receiving indication about whether the one or more devices comprises the given device; and when the one or more devices comprises the given device then attempting, by the communication device, to establish communication with the given device.
    Type: Application
    Filed: August 12, 2019
    Publication date: November 28, 2019
    Inventors: Uriel HALAVEE, Jonathan HALAVEE, Arie GAVRIELY
  • Publication number: 20190330595
    Abstract: The present invention provides human bone-marrow cells enriched with functional mitochondria, methods for their production, and therapeutic methods utilizing such cells.
    Type: Application
    Filed: June 19, 2019
    Publication date: October 31, 2019
    Applicant: MINOVIA THERAPEUTICS LTD.
    Inventors: Natalie YIVGI-OHANA, Uriel HALAVEE